Markets open

Stryker Corporation

SYK · NYSE

Sep 2026upcoming

Next quarter

Consensus is $3.63 EPS for Sep 2026 across 9 estimates, ranging $3.50 to $3.81.

SYK Jun 2026

Reported Jul 30, 2026

Beat 6.65%

EPS estimate: $3.46
EPS actual: $3.69
Revenue estimate: —
Revenue actual: —
1-day move: -6.42%

Call highlights have not been generated for this quarter.

Symbol: SYK
Type: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
Country: North America
Exchange: NYSE

Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Key Issues

Bullish view

The second quarter showed 9% organic sales growth and 17.9% adjusted EPS growth, indicating that sales momentum is returning after the cybersecurity disruption and can support renewed operating leverage.

Bearish view

Management narrowed 2026 guidance despite the earnings beat, suggesting that the recovery may be less complete or less predictable than the headline results imply.